
|Articles|April 15, 2003
B&L wins extended range on laser; delays implant application
Rochester, NY-On the same day Bausch & Lomb celebrated FDA approval of a larger treatment range for its Technolas 217A excimer laser system, it said it would delay a year before asking the FDA to approve its Retisert drug-delivery implant.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Neurotrophic keratitis outcomes improve with early, stage-based care
2
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
3
FDA feedback supports Azura’s Ophthalmic's planned NDA for AZR-MD-001 in MGD
4
Improved grading scales for oncology drugs causing ocular adverse events
5












































.png)


